Upgrade to SI Premium - Free Trial

Illumina partners with D3b to analyze 100,000 pediatric genomes

April 14, 2026 9:15 AM
Illumina (NASDAQ: ILMN) announced a data partnership with the Center for Data-Driven Discovery in Biomedicine to advance pediatric cancer and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA